T‐helper‐ and accessory‐cell‐independent cytotoxic responses to human tumor cells transfected with A B7 retroviral vector
- 1 June 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 57 (5) , 754-759
- https://doi.org/10.1002/ijc.2910570524
Abstract
As a means to increase the immunogenicity of tumor cells, we have developed a retroviral vector to transfect human B7, a molecule capable of delivering co-stimulatory signals to T cells. Three different tumors, a melanoma, an ovarian carcinoma and a myelomonocytic leukemia, were transfected with high efficiency. When compared for their capacity to stimulate allogeneic T cells, B7+ but not B7− tumor cells were able to stimulate strong proliferative and cytotoxic responses. The effector CTL generated recognised B7+ and B7− cells as well as untransfected tumor cells, indicating that B7 is required in the inductive but not the effector phase of the response. Remarkably, B7+ tumor cells were able to induce cytotoxic responses both by CD4-depleted and by CD8-purified T cells, demonstrating that expression of B7 is at the same time necessary and sufficient to induce a cytotoxic response in the absence of T-helper cells and accessory cells.Keywords
This publication has 27 references indexed in Scilit:
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Multiple levels of peripheral toleranceImmunology Today, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Molecular definition of tumor antigens recognized by T lymphocytesCurrent Opinion in Immunology, 1992
- Functional characterization of a novel anti‐B7 monoclonal antibodyEuropean Journal of Immunology, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Myeloma based expression system for production of large mammalian proteinsTrends in Biotechnology, 1991
- Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.The Journal of Experimental Medicine, 1987
- Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.The Journal of Experimental Medicine, 1985
- The same human alloreactive T cell clone can help both B lymphocytes and specific cytotoxic precursors.The Journal of Experimental Medicine, 1984